Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Interventions

Specimen Handling 327 Magnetic Resonance Spectroscopy 278 pembrolizumab 268 Carboplatin 190 Cyclophosphamide 187 Biopsy 183 Cisplatin 163 Gemcitabine 138 Paclitaxel 137 Bevacizumab 124 fludarabine 122 Nivolumab 119 Radiotherapy 116 Oxaliplatin 94 venetoclax 92 Docetaxel 90 Fluorouracil 89 Capecitabine 89 Dexamethasone 86 Drug Therapy 77 Pemetrexed 75 Rituximab 74 Leucovorin 72 durvalumab 71 Blood Specimen Collection 70 Radiosurgery 69 Standard of Care 68 atezolizumab 67 Doxorubicin 66 Radiation 63

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Escitalopram × 90 days × Clear all

NCT03728673 2026-04-17

A Study Utilizing Escitalopram in Glioma Patients

University of Nebraska

Phase 2 Recruiting

Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡